Bionano genomics, inc (BNGO)
Income statement / TTM
Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Sep'17
Revenue:
Total revenue

10,129

11,353

10,869

12,084

12,000

0

0

0

0

Cost of revenue:
Total cost of revenue

6,768

8,065

8,758

9,016

8,711

0

0

0

0

Operating expenses:
Research and development

9,080

9,194

9,526

9,217

9,484

0

0

0

0

Selling, general and administrative

20,155

18,906

17,681

16,115

14,220

0

0

0

0

Total operating expenses

29,236

28,101

27,207

25,332

23,704

0

0

0

0

Loss from operations

-25,874

-24,812

-25,096

-22,264

-20,415

0

0

0

0

Other income (expense)
Interest expense

2,286

1,683

1,509

1,351

1,381

0

0

0

0

Fair Value Adjustment of Warrants

0

-0

-1,520

-3,037

-3,991

0

0

0

0

Gain (Loss) on Extinguishment of Debt

-1,333

-921

-921

-1,263

-342

0

0

0

-

Other expenses

299

885

830

642

333

0

0

0

0

Total other income (expenses)

-3,919

-3,490

-1,741

-219

1,934

0

0

0

0

Loss before income taxes

-29,794

-28,303

-26,838

-22,484

-18,480

0

0

0

0

Income Tax Expense (Benefit)

21

22

15

16

15

0

0

0

0

Net loss

-29,815

-28,325

-26,853

-22,500

-18,496

0

0

0

0

Net loss per share, basic and diluted (USD per share)

0.08

-0.59

-0.71

-0.77

0.16

-0.63

-0.98

-1.16

-1.74

Weighted-average common shares outstanding basic and diluted (shares)

27,943

10,897

10,860

10,210

13,850

7,778

3,364

3,315

2,920

Product revenue
Total revenue

9,474

10,715

10,252

11,488

11,463

0

0

0

-

Total cost of revenue

6,495

7,736

8,562

8,841

8,562

0

0

0

-

Service and other revenue
Total revenue

655

638

616

596

537

0

0

0

-

Total cost of revenue

272

329

195

175

149

0

0

0

-